What is Exelon Patch Daily Treatment Patch?
Exelon Patch is a prescription medication that is used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease. The patch contains the active ingredient rivastigmine, which is delivered through the skin and into the bloodstream.
The recommended starting dose of the Exelon Patch is 4.6 mg/24 hours, which is applied to the skin once daily. The patch should be applied to a clean, dry, and hairless area of skin on the upper or lower back, upper arm, or chest. Each patch should be worn for 24 hours before being replaced with a new one, and a different location on the skin should be used for each patch application to avoid skin irritation.
The dosage of the Exelon Patch can be increased gradually over time, as tolerated, up to a maximum dose of 13.3 mg/24 hours. However, treatment interruptions longer than three days require retitration starting at the lowest dose.
It is important to use the Exelon Patch regularly to get the most benefit from it. To help remember, the patch should be changed at the same time each day. Patients and caregivers should carefully read and follow the patient instructions for using the Exelon Patch.
Possible side effects of the Exelon Patch include skin irritation or redness, nausea, vomiting, diarrhea, loss of appetite, weight loss, and headache. Like all medications, the Exelon Patch should only be used under the guidance of a healthcare professional and in accordance with the recommended dosage and instructions for use.
Frequently Asked Questions about exelon patch daily treatment patch
EXELON PATCH is a prescription medicine used to treat: Mild, moderate, and severe memory problems (dementia) associated with Alzheimer's disease. Mild-to-moderate memory problems (dementia) associated with Parkinson's disease (PD). Some patients will not benefit from treatment with EXELON Patch.
Exelon improves the function of nerve cells in the brain. It works by preventing the breakdown of a chemical that is important for the processes of memory, thinking, and reasoning.
The exact mechanism of rivastigmine's action is unknown, however it is thought to exert its therapeutic effect by enhancing cholinergic function. It inhibits the cholinesterase enzyme from breaking down acetylcholine, increasing both the level and duration of action of the neurotransmitter acetylcholine.
Each 5 cm2 patch contains 9 mg rivastigmine base, with in vivo release rate of 4.6 mg/24 hours. Each 10 cm2 patch contains 18 mg rivastigmine base, with in vivo release rate of 9.5 mg/24 hours. For a full list of excipients, see Description (11).
Rivastigmine, an acetylcholinesterase inhibitor, works by increasing the levels of a brain chemical called acetylcholine which allows the nerve cells to communicate. This may improve the symptoms of dementia. Rivastigmine can be taken orally, either as capsules or a liquid, or by applying a patch on the skin.
Descriptions. Rivastigmine patch is used to treat dementia (memory loss) associated with mild, moderate, or severe Alzheimer's disease, or mild to moderate dementia associated with Parkinson's disease. Rivastigmine will not cure these diseases and it will not stop these diseases from getting worse.
Cholinesterase inhibitors are the first choice of treatment for memory loss. The doctor may also prescribe the single-dose drug combination Namzeric to treat moderate to severe memory loss.
Alzheimer's disease is a condition in which changes in the brain cause problems with memory, thinking and behaviour. These problems gradually become worse with time. Exelon works by preventing the breakdown of a chemical in the brain called acetylcholine. This chemical is needed to help keep the brain working properly.
Compliance improved from baseline to 18 months and for 88.2% of patients caregivers preferred the transdermal patch to oral medications. Conclusions: The rivastigmine transdermal patch is effective in maintaining cognitive function over 18 months of treatment in patients with mild-to-moderate AD.
Rivastigmine, an acetylcholinesterase inhibitor, works by increasing the levels of a brain chemical called acetylcholine which allows the nerve cells to communicate. This may improve the symptoms of dementia.
Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Rivastigmine does not cure either of these diseases, but it may improve memory, awareness, and the ability to perform daily functions.
Safer Medications to Consider
Alternative prescription medications include ramelteon (Rozerem®), low dose trazodone (Oleptro®, Desyrel®) or low dose mirtazapine (Remeron®).
A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.
Rivastigmine, an acetylcholinesterase inhibitor, works by increasing the levels of a brain chemical called acetylcholine which allows the nerve cells to communicate. This may improve the symptoms of dementia.
Compliance improved from baseline to 18 months and for 88.2% of patients caregivers preferred the transdermal patch to oral medications. Conclusions: The rivastigmine transdermal patch is effective in maintaining cognitive function over 18 months of treatment in patients with mild-to-moderate AD.
Exelon is part of a class of drugs called cholinesterase inhibitors. It acts to reversibly block the function of acetylcholinesterase. By inhibiting this enzyme, it prevents the breakdown of the neurotransmitter acetylcholine and increases its levels in the brain.
